Nextech Invest’s Oric Pharmaceuticals ORIC Stock Holding History

Nextech Invest’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.6M	Hold	7,162,637	–	–	3.68%	6
2026 Q1	$90.8M	Hold	7,162,637	–	–	6.39%	4
2025 Q4	$58.6M	Hold	7,162,637	–	–	5.66%	4
2025 Q3	$86M	Hold	7,162,637	–	–	13.08%	2
2025 Q2	$72.7M	Buy	7,162,637 +1,876,923	+36%	+$12.6M	13.76%	2
2025 Q1	$29.5M	Hold	5,285,714	–	–	6.85%	3
2024 Q4	$42.7M	Hold	5,285,714	–	–	6.92%	3
2024 Q3	$54.2M	Hold	5,285,714	–	–	7.61%	3
2024 Q2	$37.4M	Hold	5,285,714	–	–	6.29%	6
2024 Q1	$72.7M	Buy	5,285,714 +1,000,000	+23%	+$11.9M	11.52%	2
2023 Q4	$39.4M	Hold	4,285,714	–	–	7.34%	6
2023 Q3	$25.9M	Hold	4,285,714	–	–	7.86%	5
2023 Q2	$33.3M	Buy	+4,285,714	New	+$24.3M	11.3%	3

Other funds holding ORIC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIHC Capital Management Central $104M AUM

Nextech Invest's ORIC Position: Q2 2026 in Review

Nextech Invest held its Oric Pharmaceuticals (ORIC) position steady in Q2 2026 at 7,162,637 shares worth $77.6M. The position accounts for 3.68% of the portfolio, ranked #6.

Nextech Invest first reported a position in ORIC in Q2 2023 and has held it in 13 quarters since. The position peaked at $90.8M in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Nextech Invest held 7,162,637 shares of Oric Pharmaceuticals worth $77.6M as of Q2 2026.
Nextech Invest left its Oric Pharmaceuticals share count unchanged in Q2 2026.
Oric Pharmaceuticals made up 3.68% of Nextech Invest's portfolio in Q2 2026, its #6 holding.
Nextech Invest first reported a position in Oric Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
Nextech Invest's Oric Pharmaceuticals position peaked at $90.8M in Q1 2026.
181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Nextech Invest's 13F filing for Q2 2026, filed 14 Aug 2026.